Development of fever following first administration of zoledronate as a prognostic factor in advanced non-small cell lung cancer patients with bone metastases

Nitrogen-containing bisphosphonates (N-BPs), which are usually used for the treatment of advanced cancer with bone metastasis, occasionally cause fever following the first administration. However, it is unclear as to how the development of fever following the first administration of N-BP is associat...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Mol Clin Oncol
Glavni autori: Izumi, Hiroki, Igishi, Tadashi, Yamasaki, Akira, Takeda, Kennichi, Yanai, Masaaki, Tanaka, Natsumi, Sakamoto, Tomohiro, Nishii-Ito, Shizuka, Touge, Hirokazu, Kodani, Masahiro, Matsumoto, Shingo, Kawasaki, Yuji, Shimizu, Eiji
Format: Artigo
Jezik:Inglês
Izdano: D.A. Spandidos 2017
Teme:
Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5740853/
https://ncbi.nlm.nih.gov/pubmed/29285363
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2017.1447
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items